Gramza v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided September 28, 2018·No. 15-247·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 15-247V

(not to be published)

************************* Special Master Corcoran JASMYNE GRAMZA, *

*

*

Petitioner, * Filed: August 17, 2018

*

v. *

*

SECRETARY OF HEALTH * Attorney’s Fees and Costs AND HUMAN SERVICES, *

*

Respondent. *

*

*************************

Andrew D. Downing, Van Cott & Talamante PLLC, Phoenix, AZ, for Petitioner.

Darryl R. Wishard, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION GRANTING FINAL AWARD OF ATTORNEY’S FEES AND COSTS1

On March 10, 2015, Mrs. Tarah Gramza filed a petition for compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”) on behalf of her thenminor daughter, Ms. Jasmyne Gramza.2 The Petition alleged that as a result of Human Papillomavirus (“HPV” or “Gardasil”) vaccinations that she received on January 7, 2012, July 26, 2012, and January 23, 2013, Ms. Gramza experienced immune thrombocytopenic purpura (“ITP”). Petition at 1, 6. An entitlement hearing was held in the matter on June 6-7, 2017, and post-hearing briefs were filed by the parties simultaneously on August 15, 2017. ECF Nos. 71 & 72. On

1 This Decision will be posted on the United States Court of Federal Claims’ website, in accordance with the E- Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the published Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its current form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended, 42 U.S.C. §§ 300aa-10 through 34 (2012) [hereinafter “Vaccine Act” or “the Act”]. Individual section references hereafter will be to § 300aa of the Act without inclusion of that statutory prefix.

February 5, 2018, I issued my Decision denying entitlement. Gramza v. Sec’y of Health & Human Servs., No. 15-247V, 2018 WL 1581674 (Fed. Cl. Spec. Mstr. Feb. 5, 2018). Petitioner sought review of this decision but was unsuccessful. Gramza v. Sec’y of Health & Human Servs., 2018 WL 3868838 (Fed Cl. Aug. 15, 2018).

Petitioner previously obtained an interim award of fees and costs on June 28, 2017. See Gramza v. Sec’y of Health & Human Servs., No. 15-247V, 2017 WL 3574794 (Fed. Cl. Spec. Mstr. June 28, 2017). This fees award covered the time period from the beginning of the case though the June 2017 entitlement hearing, exclusive of post-hearing briefing.

Ms. Gramza has now filed her final fees motion. See generally Motion for Final Attorney’s Fees and Costs, filed August 9, 2018 (ECF No. 89) (“Fees App.”). Petitioner specifically requests fees and costs in the total amount of $26,246.17 (representing $24,979.00 in attorney’s fees, and $1,267.17 in costs). Petitioner states that pursuant to General Order No. 9, she has not personally incurred any expenses associated with the claim. Id. at 2. Respondent reacted to the instant motion on August 10, 2018, indicating that he was satisfied the statutory requirements for an award of attorneys’ fees and costs were met, and deferring to my discretion to determine a reasonable award. ECF No. 90, at 2-3.

Analysis

I. A Final Award of Fees and Costs is Appropriate

I have in prior decisions set forth at length the criteria to be applied when determining if fees should be awarded for an unsuccessful claim. See, e.g., Allicock v. Sec’y of Health & Human Servs., No. 15-485V, 2016 WL 3571906, at *4-5 (Fed. Cl. Spec. Mstr. May 26, 2016), aff’d on other grounds, 128 Fed. Cl. 724 (2016); Gonzalez v. Sec’y of Health & Human Servs., No. 14- 1072V, 2015 WL 10435023, at *5-6 (Fed. Cl. Spec. Mstr. Nov. 10, 2015). In short, a petitioner can receive a fees award even if his claim fails, but to do so he must demonstrate the claim’s reasonable basis3 through some objective evidentiary showing and in light of the “totality of the circumstances.” The nature and extent of an attorney’s investigation into the claim’s underpinnings, both before and after filing, is a relevant consideration. Cortez v. Sec’y of Health & Human Servs., No. 09-176V, 2014 WL 1604002, at *6 (Fed. Cl. Spec. Mstr. Mar. 26, 2014); Di Roma v. Sec’y of Health & Human Servs., No. 90–3277V, 1993 WL 496981, at *2 (Fed. Cl. Spec. Mstr. Nov. 18, 1993) (citing Lamb v. Sec'y of Health & Human Servs., 24 Cl. Ct. 255, 258–59 (1991)).

3 Although good faith is one of the two criteria that an unsuccessful petitioner requesting a fees award must satisfy, it is an easily-met one – and Respondent does not appear to question it in this case. Grice v. Sec’y of Health & Human Servs., 36 Fed. Cl. 114, 121 (1996) (in the absence of evidence of bad faith, special master was justified in presuming the existence of good faith).

The Court of Federal Claims recently provided further illumination as to the standards that should be used to evaluate whether the totality of the circumstances warrant a finding that reasonable basis existed. Cottingham v. Sec’y of Health & Human Servs., No. 15-1291V, 2017 WL 4546579, at *10 (Fed. Cl. Oct. 12, 2017). As Judge Williams therein stated, a special master should consider “the novelty of the vaccine, scientific understanding of the vaccine and its potential consequences, the availability of experts and medical literature, and the time frame counsel has to investigate and prepare the claim.” Id. at *5. Additionally, the Court may look at whether appellate litigation had a reasonable basis when determining whether such work is compensable under the program. See Hirmiz v. Sec’y of Health & Human Servs., 135 Fed. Cl. 260, 270 (Fed. Cl. 2017).

Here, I do not find that Petitioner’s post-hearing appellate efforts were completely in vain, or that her appeal did not raise reasonably-disputed points. Indeed, the Court of Federal Claims devoted not-insubstantial attention to her arguments, as reflected in the detailed level of analysis provided. Accordingly, I find no grounds upon which to deny a final fees award in this case.

II. Calculating Amount of Final Award

I must now evaluate what amount of award is proper. In any Vaccine Program case in which fees are sought, the requested sum must be “reasonable.” Section 15(e)(1). Special masters may in their discretion reduce attorney hours sua sponte, apart from objections raised by Respondent and without providing a petitioner notice and opportunity to respond. See Sabella v. Sec’y of Health & Human Servs., 86 Fed. Cl. 201, 208-09 (2009); Perreira v. Sec’y of Health & Human Servs., 27 Fed. Cl. 29, 34 (Fed. Cl. 1992) (special master has “wide discretion in determining the reasonableness” of attorney’s fees and costs).

Determining the appropriate amount of an award of reasonable attorney’s fees is a two-part process. The first part involves application of the lodestar method – “multiplying the number of hours reasonably expended4 on the litigation times a reasonable hourly rate.” Avera v. Sec’y of

Free access — add to your briefcase to read the full text and ask questions with AI

Gramza v. Secretary of Health and Human Services, (uscfc 2018).

Gramza v. Secretary of Health and Human Services (Gramza v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related